• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡和美国医院中与溶栓治疗使用相关的中风因素:一项跨登记比较研究。

Stroke Factors Associated with Thrombolysis Use in Hospitals in Singapore and US: A Cross-Registry Comparative Study.

机构信息

Saw Swee Hock School of Public Health, National University Health System, Singapore, Singapore.

Department of Neurology, Program in Occupational Therapy, Washington University in St Louis, St. Louis, Missouri, USA.

出版信息

Cerebrovasc Dis. 2019;47(5-6):291-298. doi: 10.1159/000502278. Epub 2019 Aug 21.

DOI:10.1159/000502278
PMID:31434100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6759403/
Abstract

BACKGROUND AND OBJECTIVES

This paper aims to describe and compare the characteristics of 2 stroke populations in Singapore and in St. Louis, USA, and to document thrombolysis rates and contrast factors associated with its uptake in both populations.

METHODS

The stroke populations described were from the Singapore Stroke Registry (SSR) in -Singapore and the Cognitive Rehabilitation Research Group Stroke Registry (CRRGSR) in St. Louis, MO, USA. The registries were compared in terms of demographics and stroke risk factor history. Logistic regression was used to determine factors associated with thrombolysis uptake.

RESULTS

A total of 39,323 and 8,106 episodes were recorded in SSR and CRRGSR, respectively, from 2005 to 2012. Compared to CRRGSR, patients in SSR were older, male, and from the ethnic majority. Thrombolysis rates in SSR and CRRGSR were 2.5 and 8.2%, respectively, for the study period. History of ischemic heart disease or atrial fibrillation was associated with increased uptake in both populations, while history of stroke was associated with lower uptake. For SSR, younger age and males were associated with increased uptake, while having a history of smoking or diabetes was associated with decreased uptake. For CRRGSR, ethnic minority status was associated with decreased uptake.

CONCLUSIONS

The comparison of stroke populations in Singapore and St Louis revealed distinct differences in clinicodemographics of the 2 groups. Thrombolysis uptake was driven by nonethnicity demographics in Singapore. Ethnicity was the only demographic driver of uptake in the CRRGSR population, highlighting the need to target ethnic minorities in increasing access to thrombolysis.

摘要

背景与目的

本文旨在描述和比较新加坡和美国密苏里州圣路易斯的两个卒中人群的特征,并记录溶栓治疗的比例以及两个人群中与溶栓治疗相关的因素。

方法

本文描述的卒中人群来自新加坡卒中登记处(SSR)和美国密苏里州圣路易斯认知康复研究组卒中登记处(CRRGSR)。这两个登记处从人口统计学和卒中危险因素史方面进行了比较。采用 logistic 回归确定与溶栓治疗相关的因素。

结果

2005 年至 2012 年,SSR 和 CRRGSR 分别记录了 39323 例和 8106 例卒中发作。与 CRRGSR 相比,SSR 中的患者年龄较大、男性比例较高、来自主要种族。SSR 和 CRRGSR 在研究期间的溶栓治疗比例分别为 2.5%和 8.2%。缺血性心脏病或心房颤动史与两个人群的溶栓治疗使用率增加有关,而卒中史与溶栓治疗使用率降低有关。对于 SSR,年龄较小和男性与溶栓治疗使用率增加有关,而吸烟或糖尿病史与溶栓治疗使用率降低有关。对于 CRRGSR,少数民族身份与溶栓治疗使用率降低有关。

结论

新加坡和圣路易斯卒中人群的比较揭示了两组人群在临床特征方面的显著差异。新加坡溶栓治疗的使用率取决于非种族人口统计学因素。种族是 CRRGSR 人群中唯一与溶栓治疗使用率相关的人口统计学因素,这突出表明需要针对少数民族,以增加其获得溶栓治疗的机会。

相似文献

1
Stroke Factors Associated with Thrombolysis Use in Hospitals in Singapore and US: A Cross-Registry Comparative Study.新加坡和美国医院中与溶栓治疗使用相关的中风因素:一项跨登记比较研究。
Cerebrovasc Dis. 2019;47(5-6):291-298. doi: 10.1159/000502278. Epub 2019 Aug 21.
2
Analyses of the Turkish National Intravenous Thrombolysis Registry.土耳其国家静脉溶栓登记研究分析
J Stroke Cerebrovasc Dis. 2016 May;25(5):1041-1047. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.015. Epub 2016 Feb 4.
3
Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.亚洲患者静脉注射组织型纤溶酶原激活剂使用评分系统的推导与验证
J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1695-1703. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.033. Epub 2017 Apr 10.
4
Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.新加坡多民族亚洲卒中患者静脉溶栓的可行性和安全性。
J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):424-30. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.015.
5
Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial.强化血压控制与溶栓治疗急性缺血性脑卒中试验中亚洲与非亚洲溶栓患者的差异。
Cerebrovasc Dis. 2021;50(5):560-566. doi: 10.1159/000516487. Epub 2021 Jun 21.
6
Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.接受溶栓治疗的急性缺血性卒中患者院内死亡和有症状颅内出血的预测因素:保罗·科弗代尔急性卒中登记研究(2008 - 2012年)
Int J Stroke. 2014 Aug;9(6):728-34. doi: 10.1111/ijs.12155. Epub 2013 Sep 12.
7
Safety of protocol violations in acute stroke tPA administration.急性卒中 tPA 给药中违反方案的安全性。
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):855-60. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.019. Epub 2013 Aug 15.
8
The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.中国与北美急性缺血性卒中溶栓后出血转化风险的比较研究
J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2381-2387. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.027. Epub 2018 May 31.
9
Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.知情同意政策的变化与卒中溶栓治疗的延误。
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105551. doi: 10.1016/j.jstrokecerebrovasdis.2020.105551. Epub 2020 Dec 19.
10
Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.年龄较大并不会增加急性卒中静脉和/或动脉内溶栓后出血并发症的风险。
J Stroke Cerebrovasc Dis. 2008 Sep;17(5):266-72. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.003.

引用本文的文献

1
Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS): A Comprehensive Meta-Analysis of Ethnicity, Socioeconomic Status, and Geographical Factors.急性缺血性中风再灌注治疗可及性差异(DARTS):种族、社会经济地位和地理因素的综合荟萃分析
CNS Drugs. 2025 Apr;39(4):417-442. doi: 10.1007/s40263-025-01161-z. Epub 2025 Feb 15.
2
Estimated potassium intake and major adverse cardiovascular events in individuals with type 2 diabetes: a prospective cohort study with trans-ethnic validation.2型糖尿病患者的估计钾摄入量与主要不良心血管事件:一项跨种族验证的前瞻性队列研究
Cardiovasc Diabetol. 2024 Dec 21;23(1):451. doi: 10.1186/s12933-024-02546-y.
3
Quality Indicators and Clinical Outcomes of Acute Stroke: Results from a Prospective Multicenter Registry in Greece (SUN4P).急性卒中的质量指标与临床结局:希腊一项前瞻性多中心注册研究(SUN4P)的结果
J Clin Med. 2024 Feb 5;13(3):917. doi: 10.3390/jcm13030917.
4
Arrival time at a referral hospital and functional disability of people with stroke: a cohort study.到达转诊医院的时间与卒中患者的功能障碍:一项队列研究。
Sao Paulo Med J. 2023 May 12;141(6):e2022510. doi: 10.1590/1516-3180.2022.0510.R1.27022023. eCollection 2023.
5
Early Hospital Arrival After Acute Ischemic Stroke Is Associated With Family Members' Knowledge About Stroke.急性缺血性卒中后早期入院与家庭成员对卒中的认知有关。
Front Neurol. 2021 May 26;12:652321. doi: 10.3389/fneur.2021.652321. eCollection 2021.
6
Recovery from stroke: current concepts and future perspectives.中风康复:当前概念与未来展望。
Neurol Res Pract. 2020 Jun 16;2:17. doi: 10.1186/s42466-020-00060-6. eCollection 2020.

本文引用的文献

1
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家315种疾病和损伤的伤残调整生命年(DALYs)及健康预期寿命(HALE):全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X.
2
Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球 188 个国家 1990-2013 年卒中负担和风险因素:2013 年全球疾病负担研究的系统分析。
Lancet Neurol. 2016 Aug;15(9):913-924. doi: 10.1016/S1474-4422(16)30073-4. Epub 2016 Jun 9.
3
Restriction of therapy mainly explains lower thrombolysis rates in reduced stroke service levels.治疗受限主要解释了在卒中服务水平降低的情况下溶栓率较低的原因。
Neurology. 2016 May 24;86(21):1975-83. doi: 10.1212/WNL.0000000000002695. Epub 2016 Apr 22.
4
How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.我们如何提高中风溶栓率?对急性中风护理中与溶栓给药率相关的卫生系统因素和方法的综述。
Implement Sci. 2016 Apr 8;11:51. doi: 10.1186/s13012-016-0414-6.
5
Risk factors for ischemic stroke and its subtypes in Chinese vs. Caucasians: Systematic review and meta-analysis.中国人群与高加索人群缺血性卒中及其亚型的危险因素:系统评价与荟萃分析。
Int J Stroke. 2015 Jun;10(4):485-93. doi: 10.1111/ijs.12508. Epub 2015 Apr 23.
6
Countrywide stroke incidence, subtypes, management and outcome in a multiethnic Asian population: the Singapore Stroke Registry--methodology.多民族亚洲人群中的全国性卒中发病率、亚型、管理及结局:新加坡卒中登记——方法学
Int J Stroke. 2015 Jul;10(5):767-9. doi: 10.1111/ijs.12472. Epub 2015 Mar 5.
7
Risk factors of stroke in Western and Asian countries: a systematic review and meta-analysis of prospective cohort studies.西方国家和亚洲国家中风的危险因素:前瞻性队列研究的系统评价和荟萃分析
BMC Public Health. 2014 Jul 31;14:776. doi: 10.1186/1471-2458-14-776.
8
Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.急性缺血性卒中患者在卒中严重程度、预后及治疗方面的种族和性别差异。
J Stroke Cerebrovasc Dis. 2014 Apr;23(4):e255-61. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.003. Epub 2014 Jan 25.
9
National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010.2003-2010 年台湾急性缺血性脑卒中溶栓治疗的全国性调查。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e620-7. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.043. Epub 2013 Oct 11.
10
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.参与“遵循卒中指南”项目的医院中急性缺血性卒中患者的特征及静脉溶栓治疗的时间趋势。
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):543-9. doi: 10.1161/CIRCOUTCOMES.111.000303.